Pediatric Brain Cancer Trial Group to Be Phased Out
Pediatric Brain Cancer Trial Group to Be Phased Out
A network of hospitals and cancer centers dedicated to early phase trials of novel treatments will no longer receive federal funding.
Read the full article on NY Times Politics
Truth Analysis
Analysis Summary:
The article appears mostly accurate, with the core claim of funding being phased out supported by FierceBiotech (source 2). There's a slight bias due to the negative framing of the funding change, but the information is presented factually. The impact of this change is not fully explored, leading to some potential for selective reporting.
Detailed Analysis:
- Claim: A network of hospitals and cancer centers dedicated to early phase trials of novel treatments will no longer receive federal funding.
- Verification Source #2: The NCI has concluded expanding support for the Children's Oncology Group Pediatric Early Phase-Clinical Trials Network is the best use of funds, implying a shift away from the current network.
- Assessment: Supported by source 2. The source confirms the NCI is shifting funding, which implies the network mentioned in the article will no longer receive it.
Supporting Evidence/Contradictions:
- Source 2: "The NCI has concluded expanding support for the Children's Oncology Group Pediatric Early Phase-Clinical Trials Network is the best use of funds..."